Investors’ Patience Is Being Tested Right Now By Thermo Fisher Scientific Inc. (NYSE: TMO)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Thermo Fisher Scientific Inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. The current market capitalization of Thermo Fisher Scientific Inc. is $203.02B. A total of 1.57 million shares were traded on the day, compared to an average of 1.50M shares.

In the most recent transaction, CASPER MARC N sold 10,000 shares of TMO for 570.16 per share on Jun 04 ’24. After the transaction, the Chairman & CEO now owns 123,816 company shares. In a previous transaction on Jun 03 ’24, CASPER MARC N sold 10,000 shares at 567.28 per share. TMO shares that Chairman & CEO owns now total 123,816.

Among the insiders who sold shares, Lagarde Michel disposed of 20,000 shares on May 14 ’24 at a per-share price of $590.05. This resulted in the Executive Vice President & COO holding 18,134 shares of TMO after the transaction. In another insider transaction, Williamson Stephen sold 21,925 shares at $591.27 per share on May 13 ’24. Company shares held by the Sr. VP and CFO now total 36,482.


It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Thermo Fisher Scientific Inc. pays an annual dividend of $1.48, resulting in a dividend yield of 0.28%, and it has a price to earnings (P/E) ratio of 34.12. TMO’s most recent ex-dividend date was 6/14/2024 when it declared a $0.39 quarterly dividend that was paid in cash on 7/15/2024. Previously, the company paid the dividend on 4/15/2024 with an ex-dividend date of 3/14/2024. The TMO stock dividend was $0.39 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TMO has a high of $603.82 and a low of $415.60.

As of this writing, TMO has an earnings estimate of $5.12 per share for the current quarter. EPS was calculated based on a consensus of 21.0 estimates, with a high estimate of $5.2 per share and a lower estimate of $5.07. The company reported an EPS of $5.15 in the last quarter

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TMO’s latest balance sheet shows that the firm has $4.48B in Cash & Short Term Investments as of fiscal 2021. There were $34.87B in debt and $13.44B in liabilities at the time. Its Book Value Per Share was $119.24, while its Total Shareholder’s Equity was $40.98B.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Buy with a score of 4.42.

Most Popular

Related Posts